Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Anavex Life Sciences Corporation (NASDAQ: AVXL) was $8.8 for the day, up 2.03% from the previous closing price of $8.62. In other words, the price has increased by $2.03 from its previous closing price. On the day, 1.11 million shares were traded. AVXL stock price reached its highest trading level at $9.0382 during the session, while it also had its lowest trading level at $8.0589.
Ratios:
Our analysis of AVXL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.93 and its Current Ratio is at 8.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.
On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 755436288 and an Enterprise Value of 654272256.
Stock Price History:
The Beta on a monthly basis for AVXL is 0.94, which has changed by 0.59185517 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, AVXL has reached a high of $14.44, while it has fallen to a 52-week low of $5.22. The 50-Day Moving Average of the stock is -7.42%, while the 200-Day Moving Average is calculated to be -6.68%.
Shares Statistics:
AVXL traded an average of 1.17M shares per day over the past three months and 1793930 shares per day over the past ten days. A total of 85.41M shares are outstanding, with a floating share count of 82.98M. Insiders hold about 3.40% of the company’s shares, while institutions hold 38.21% stake in the company. Shares short for AVXL as of 1759190400 were 25107307 with a Short Ratio of 21.45, compared to 1756425600 on 25510330. Therefore, it implies a Short% of Shares Outstanding of 25107307 and a Short% of Float of 30.220000000000002.
Earnings Estimates
The market rating of Anavex Life Sciences Corporation (AVXL) is currently shaped by the ongoing analysis conducted by 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.56 and -$0.58 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is $2.37, with 2.0 analysts recommending between $5.23 and -$0.49.
